Current status of MaaT Pharma shares and voting rights

MaaT Pharma, an advanced biotechnology company based in Lyon, announced the number of shares and voting rights comprising its share capital as of June 30, 2026. The company, listed on Euronext Paris under ISIN code FR0012634822, has a total of 18,863,543 shares. This figure also reflects the theoretical voting rights as defined by the AMF (French Financial Markets Authority).

Nevertheless, the actual voting rights, that is, those exercisable at shareholder meetings, amount to 18,817,925. This difference takes into account shares deprived of voting rights. MaaT Pharma continues to distinguish itself in the market with its innovative Microbiome Ecosystem Therapies™.